Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

0.5432
-0.0093-1.68%
Post-market: 0.5305-0.0127-2.34%19:49 EDT
Volume:829.69K
Turnover:446.87K
Market Cap:4.01M
PE:-0.08
High:0.5754
Open:0.5600
Low:0.5079
Close:0.5525
52wk High:8.44
52wk Low:0.5079
Shares:7.37M
Float Shares:6.62M
Volume Ratio:1.70
T/O Rate:12.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.8107
EPS(LYR):-8.5775
ROE:-207.29%
ROA:-63.64%
PB:1.17
PE(LYR):-0.06

Loading ...

Aethlon Medical trading halted, news pending

TIPRANKS
·
Yesterday

Aethlon Medical Inc - Authorizes 1-for-10 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Oct 16

Aethlon Medical Announces 1-for-10 Reverse Stock Split Effective October 16, 2025

Reuters
·
Oct 16

BRIEF-Aethlon Medical's Hemopurifier® Shows Changes In Extracellular Vesicles, Extracellular Micrornas, And T Cell Numbers In Australian Oncology Clinical Trial

Reuters
·
Oct 07

Aethlon Medical Announces Promising Early Data from Australian Clinical Trial of Hemopurifier® in Cancer Patients Resistant to Anti-PD-1 Therapy

Reuters
·
Oct 07

Aethlon Medical Announces New Share Structure Update

TIPRANKS
·
Sep 13

Aethlon Medical Inc. Announces $4.5 Million Public Offering of Common Stock and Warrants

Reuters
·
Sep 10

Aethlon Medical Inc. Announces $4.5 Million Public Offering of Common Stock and Warrants

Reuters
·
Sep 04

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

THOMSON REUTERS
·
Sep 04

Aethlon Medical Inc. Unveils Presentation on Hemopurifier® Blood Purification Device and Its Potential in Oncology and Infectious Disease Treatment

Reuters
·
Sep 04

Aethlon Medical Inc. Announces New Hemopurifier® Patent Issuances for Long COVID and COVID-19-Associated Coagulopathy Treatment

Reuters
·
Sep 03

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long Covid and Covid-19-Associated Coagulopathy (Cac)

THOMSON REUTERS
·
Sep 03

Aethlon Medical Inc. Unveils Corporate Presentation Highlighting Hemopurifier® Blood Purification Device and Breakthrough Designations

Reuters
·
Aug 21

BRIEF-Aethlon Medical Files For Offering Of Common Stock And Accompanying Warrants

Reuters
·
Aug 21

Aethlon Medical Inc: Files for Offering of Common Stock and Accompanying Warrants, Size Not Disclosed- SEC Filing

THOMSON REUTERS
·
Aug 21

Aethlon Medical Price Target Maintained With a $1.50/Share by HC Wainwright & Co.

Dow Jones
·
Aug 14

Aethlon Medical Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 14

Aethlon Medical Q1 EPS $(0.85) Beats $(0.86) Estimate

Benzinga
·
Aug 14

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

THOMSON REUTERS
·
Aug 14

Aethlon Medical Inc - India Oncology Trial Delayed Until 2026

THOMSON REUTERS
·
Aug 14